Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other infection carrier state complicating the puerperium
- ICD-10 Code: O99.835
Summary
This code represents a maternal carrier state of an infectious agent that complicates the puerperium (postpartum period). The carrier state indicates colonization with the organism without active infection, but it poses risks for transmission to the newborn during delivery or postpartum care. Management focuses on preventing neonatal infection while addressing maternal colonization status.
Causes
The underlying cause is colonization with an infectious agent, such as bacteria, viruses, or other pathogens, commonly found in the maternal flora. The carrier state occurs when the organism is present without causing symptoms in the mother. Pregnancy-related hormonal and immunological changes may influence colonization dynamics, but the primary factor is the presence of the infectious agent in the maternal system.
Risk Factors
- Prior colonization with the infectious agent in previous pregnancies
- Prolonged rupture of membranes (≥18 hours)
- Preterm labor (before 37 weeks)
- Intrapartum fever or chorioamnionitis
- Maternal bacteriuria or viral shedding during pregnancy
- Prior infant with invasive disease from the same agent
Symptoms
The carrier state is typically asymptomatic. Maternal symptoms, if present, may include mild localized discomfort or discharge, but these are not always indicative of active infection. Newborns may develop symptoms of infection if transmission occurs during delivery or postpartum contact.
Diagnosis
Diagnosis involves identifying the infectious agent through screening tests (e.g., cultures, PCR, or antigen detection) during the puerperium. Maternal samples (e.g., vaginal, rectal, or throat swabs) are typically collected to detect colonization. Neonatal testing may be performed if exposure is suspected, especially for high-risk pathogens like Group B Streptococcus.
Treatment Options
Management focuses on preventing neonatal infection. This may include intrapartum antibiotic prophylaxis for known carriers of certain pathogens (e.g., Group B Streptococcus) and postpartum monitoring of both mother and infant. Maternal colonization may resolve spontaneously, but targeted treatment is considered for persistent or high-risk agents.
Prognosis and Follow-Up
Prognosis is generally favorable if appropriate preventive measures are taken. Maternal colonization often resolves without long-term effects, but neonatal infection can lead to serious complications if untreated. Follow-up involves monitoring for signs of infection in the mother and infant, with repeat testing if colonization persists.
Complications
Complications may include neonatal sepsis, pneumonia, or meningitis if transmission occurs. Maternal complications are rare but can include localized infection or recurrence of colonization. Untreated neonatal infection carries significant morbidity and mortality risks.
Lifestyle & Prevention
Preventive measures include prenatal screening for high-risk pathogens, intrapartum antibiotic prophylaxis when indicated, and strict hygiene practices during postpartum care. Maternal education on signs of infection and newborn monitoring is also critical.
When to Seek Professional Help
Seek medical attention if the mother develops fever, unusual discharge, or other signs of infection during the puerperium, or if the newborn shows signs of illness (e.g., poor feeding, lethargy, or respiratory distress).
Tips for Medical Coders
Document the specific infectious agent (if known) and the timing of colonization relative to the puerperium. Ensure the carrier state is clearly distinguished from active infection, as this impacts coding and management. Verify that the code is used only for complications during the puerperium, not pregnancy or childbirth.
O99.835 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.